FarmaKology’s Substack

FarmaKology’s Substack

Share this post

FarmaKology’s Substack
FarmaKology’s Substack
FarmaKology-Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Copy link
Facebook
Email
Notes
More

FarmaKology-Pfizer’s ELREXFIO™ Receives U.S…

FarmaKology
Aug 16, 2023
1

Share this post

FarmaKology’s Substack
FarmaKology’s Substack
FarmaKology-Pfizer’s ELREXFIO™ Receives U.S. FDA Accelerated Approval for Relapsed or Refractory Multiple Myeloma
Copy link
Facebook
Email
Notes
More

Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to "abdul@farmakology.com", and happy to have you featured on our newsletter+17K Subs.

Read →
Comments
User's avatar
© 2025 FarmaKology
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More